BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Vistin Pharma ASA: First quarter 2026 financial results

  April 24, 2026

   · 

  1 min read
• Press Releases

  Interim Report January - March 2026

  April 24, 2026

   · 

  3 min read
• Press Releases

  Novartis receives positive CHMP opinion for Itvisma® for spinal muscular atrophy (SMA)

  April 24, 2026

   · 

  8 min read
• Press Releases

  New Study Highlights Safety and Efficacy Profile of Haemonetics’ VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures

  April 24, 2026

   · 

  5 min read
• Press Releases

  ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET

  April 24, 2026

   · 

  1 min read
• Press Releases

  Senzime Publishes Annual and Sustainability Report for 2025

  April 24, 2026

   · 

  1 min read
• Press Releases

  Arrowhead Pharmaceuticals Receives Positive CHMP Opinion Recommending Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS) in Europe

  April 24, 2026

   · 

  10 min read
• Press Releases

  Sensient Technologies Corporation Reports Results for the Quarter Ended March 31, 2026

  April 24, 2026

   · 

  15 min read
• Press Releases

  Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company

  April 24, 2026

   · 

  11 min read
• Press Releases

  Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.

  April 24, 2026

   · 

  6 min read